The immune system employs several checkpoint pathways to regulate responses, maintain
homeostasis and prevent self-reactivity and autoimmunity. Tumor cells can hijack these …

Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2,
there is little information about vaccine efficacy against variants of concern (VOC) in …

There is an urgent need to understand the nature of immune responses against SARS-CoV-2,
to inform risk-mitigation strategies for people living with HIV (PLWH). Here we show that …

SARS-CoV-2 infection elicits similar antibody responses in HIV-negative individuals and
people living with HIV that is well controlled by antiretroviral therapy (ART). 1 SARS-CoV-2 …

Detection of viral DNA by cyclic GMP ‐ AMP synthase ( cGAS ) is a first line of defence leading
to the production of type I interferon ( IFN ). As HIV ‐1 replication is not a strong inducer of …

We assessed a cohort of people living with human immunodeficiency virus (PLWH) (n = 110)
and HIV negative controls (n = 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all …

With an estimated three to five million human cases annually and the potential to infect
domestic and wild animal populations, influenza viruses are one of the greatest health and …

Patients with haematological malignancies are more likely to have poor responses to vaccination.
Here we provide detailed analysis of the humoral and cellular responses to COVID‐19 …

Natural killer (NK) cell subsets with adaptive properties are emerging as regulators of
vaccine-induced T and B cell responses and are specialized towards antibody-dependent …

Antigen-specific antibody infusion is known to enhance or suppress germinal center (GC)
responses depending on the affinity of the infusion. We hypothesized that infusing monoclonal …